Log In
Print this Print this

Xolegel, ketoconazole

Also known as: formerly Sebazole

  Manage Alerts
Collapse Summary General Information
Company Almirall S.A.
DescriptionTopical gel formulation of 2% ketoconazole
Molecular Target Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of ActionCytochrome P450 C-14 alpha demethylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsTreat seborrheic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today